feed,title,long_url,short_url
BioRxiv,Molnupiravir (MK-4482) is efficacious against Omicron and other SARS-CoV-2 variants in the Syrian hamster COVID-19 model,https://biorxiv.org/cgi/content/short/2022.02.22.481491v1?rss=1,https://bit.ly/35ngOw6
BioRxiv,Ivermectin does not protect against SARS-CoV-2 infection in the Syrian hamster model,https://biorxiv.org/cgi/content/short/2022.02.22.481472v1?rss=1,https://bit.ly/3JRTdTi
BioRxiv,SARS-CoV-2 peptide vaccine elicits T-cell responses in mice but does not protect against infection or disease,https://biorxiv.org/cgi/content/short/2022.02.22.481499v1?rss=1,https://bit.ly/3vesfkP
BioRxiv,Biophysical fitness landscape of the SARS-CoV-2 Delta variant receptor binding domain,https://biorxiv.org/cgi/content/short/2022.02.21.481311v1?rss=1,https://bit.ly/3JUSn8x
